Pre-Thrombectomy Assessment: Critical Exclusion Criteria
Before proceeding with thrombectomy, the most critical thing to confirm is the absence of recent ischemic stroke within the preceding 6 months, as this represents an absolute contraindication to adjunctive thrombolytic therapy and significantly increases hemorrhagic risk. 1
Absolute Contraindications to Verify
When a surgeon plans thrombectomy, you must systematically exclude the following absolute contraindications:
Stroke-Related History
- Hemorrhagic stroke or stroke of unknown origin at any time in the patient's history - this is an absolute contraindication that cannot be overridden 1
- Ischemic stroke within the preceding 6 months - this represents an absolute contraindication to fibrinolytic therapy that may be used adjunctively 1
- Central nervous system damage, tumors, or neoplasms - these conditions preclude safe thrombectomy with thrombolysis 1
Recent Trauma and Surgery
- Major trauma, surgery, or head injury within the preceding 3 weeks - this is an absolute contraindication in most contexts 1
- However, in the context of immediately life-threatening, high-risk pulmonary embolism, recent surgery may become a relative rather than absolute contraindication 1
Active Bleeding Risks
- Gastrointestinal bleeding within the last month - absolute contraindication 1
- Known active bleeding disorder - must be excluded 1
Time-Sensitive Imaging Requirements
For Stroke Thrombectomy (0-6 Hours)
- Noncontrast CT head must be performed immediately to exclude hemorrhage and assess ASPECTS score 2
- CT angiography should be obtained simultaneously to identify large vessel occlusion 2
- ASPECTS score ≥6 and NIHSS ≥6 are required for patient selection 2
For Extended Window (6-24 Hours)
- CT perfusion or DW-MRI with perfusion is mandatory to demonstrate sizable mismatch between ischemic core and hypoperfusion area 2
- Strict adherence to DAWN or DEFUSE-3 criteria is required when selecting patients beyond 6 hours 2
Blood Pressure Management
Pre-Thrombectomy Targets
- For patients potentially eligible for thrombolysis: systolic BP <185 mmHg and diastolic BP <110 mmHg 1
- Refractory hypertension (systolic BP >180 mmHg) represents a relative contraindication to thrombolysis 1
Laboratory Assessment
- aPTT and INR should be obtained but must not delay the procedure 2
- Only blood glucose measurement must precede any IV thrombolytic therapy 2
- For patients on vitamin K antagonists: INR must be <1.7 for safe thrombolysis 3
Common Pitfalls to Avoid
Anticoagulation Status
- Patients on novel oral anticoagulants (NOACs) have minimal safety data for thrombolysis - coagulation parameters should be checked to assess eligibility 3
- Oral anticoagulant therapy represents a relative contraindication requiring careful assessment 1
Timing Errors
- Do not delay imaging to obtain complete stroke history if the patient is within the treatment window 2
- Early transfer to thrombectomy-capable centers is essential for patients at risk, rather than delaying for complete workup 4
Clinical Scale Limitations
- Clinical scales alone (without CTA) have high false-positive rates - 68% of transfers without pre-transfer CTA did not have large vessel occlusion 5
- NIHSS <10 had 88% non-treatment rate after transfer, suggesting the need for vascular imaging before transfer decisions 5